Literature DB >> 28785563

Underlying Mechanisms for Distant Metastasis - Molecular Biology.

Eva Pachmayr1,2, Christoph Treese1,2,3,4, Ulrike Stein1,2,5.   

Abstract

BACKGROUND: The formation of distant metastases constitutes a complex process with a variety of different genes and pathways involved. To improve patient survival, it is necessary to understand the underlying mechanisms of metastasis to allow for targeted intervention.
METHODS: This review provides an overview of the general concepts of metastasis, focusing on the most important genes and pathways involved and on interventional strategies.
RESULTS: Cancer cells undergo different steps to form metastasis: most prominently, local invasion, intravasation, survival in the circulation, arrest at a distant organ site and extravasation, micrometastasis formation, and metastatic colonization. In order to pass these steps, different molecular pathways are of major importance: EGF/RAS/RAF/MEK/ERK, PI3K/Akt/mTOR, HGF/Met, Wnt/β-catenin, and VEGF signaling. The HGF/Met regulator MACC1 and the Wnt signaling target S100A4 have been shown to play a major role in the metastatic process. Each gene and pathway provides an opportunity for therapeutic intervention.
CONCLUSION: Since metastasis represents a highly limiting factor in cancer therapy causing 90% of cancer deaths, it is imperative to reveal the underlying mechanisms. This is fundamental for uncovering prognostic markers and new targeted therapy options.

Entities:  

Keywords:  Cancer therapy; Metastasis; Molecular mechanism

Year:  2017        PMID: 28785563      PMCID: PMC5520302          DOI: 10.1159/000454696

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


  109 in total

1.  Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

Authors:  José Baselga; Mario Campone; Martine Piccart; Howard A Burris; Hope S Rugo; Tarek Sahmoud; Shinzaburo Noguchi; Michael Gnant; Kathleen I Pritchard; Fabienne Lebrun; J Thaddeus Beck; Yoshinori Ito; Denise Yardley; Ines Deleu; Alejandra Perez; Thomas Bachelot; Luc Vittori; Zhiying Xu; Pabak Mukhopadhyay; David Lebwohl; Gabriel N Hortobagyi
Journal:  N Engl J Med       Date:  2011-12-07       Impact factor: 91.245

2.  The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA.

Authors:  Zhong-Hua Li; Anne R Bresnick
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

3.  The tumor microenvironment at a glance.

Authors:  Frances R Balkwill; Melania Capasso; Thorsten Hagemann
Journal:  J Cell Sci       Date:  2012-12-01       Impact factor: 5.285

Review 4.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

5.  Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/extracellular signal-regulated kinase (ERK) signaling pathway.

Authors:  J P Irigoyen; D Besser; Y Nagamine
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

Review 6.  Wnt/beta-catenin signaling in cancer stemness and malignant behavior.

Authors:  Riccardo Fodde; Thomas Brabletz
Journal:  Curr Opin Cell Biol       Date:  2007-02-16       Impact factor: 8.382

Review 7.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

8.  Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015.

Authors:  C-H Köhne; J De Greve; J T Hartmann; I Lang; P Vergauwe; K Becker; D Braumann; E Joosens; L Müller; J Janssens; C Bokemeyer; P Reimer; H Link; E Späth-Schwalbe; H-J Wilke; H Bleiberg; J Van Den Brande; M Debois; U Bethe; E Van Cutsem
Journal:  Ann Oncol       Date:  2007-12-06       Impact factor: 32.976

Review 9.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

Authors:  Alexander Greenhough; Helena J M Smartt; Amy E Moore; Heather R Roberts; Ann C Williams; Christos Paraskeva; Abderrahmane Kaidi
Journal:  Carcinogenesis       Date:  2009-01-09       Impact factor: 4.944

10.  Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.

Authors:  Ying-Chun Zhao; Xiao-Jian Ni; Yong Li; Min Dai; Zhong-Xu Yuan; Yong-Yun Zhu; Chuan-Yu Luo
Journal:  World J Surg Oncol       Date:  2012-08-20       Impact factor: 2.754

View more
  36 in total

1.  Oligometastases of Gastrointestinal Cancer Origin.

Authors:  Nancy E Kemeny; Beate Rau
Journal:  Visc Med       Date:  2017-02-22

Review 2.  Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview.

Authors:  Miguel Alberto; Andreas Brandl; Pankaj Kumar Garg; Safak Gül-Klein; Mathias Dahlmann; Ulrike Stein; Beate Rau
Journal:  Clin Exp Metastasis       Date:  2019-02-04       Impact factor: 5.150

3.  Vitamin D Sufficiency Has a Limited Effect on Placental Structure and Pathology: Placental Phenotypes in the VDAART Trial.

Authors:  Mai He; Hooman Mirzakhani; Ling Chen; Robert Wu; Augusto A Litonjua; Leonard Bacharier; Scott T Weiss; D Michael Nelson
Journal:  Endocrinology       Date:  2020-06-01       Impact factor: 4.736

Review 4.  The role of metabolic ecosystem in cancer progression - metabolic plasticity and mTOR hyperactivity in tumor tissues.

Authors:  Anna Sebestyén; Titanilla Dankó; Dániel Sztankovics; Dorottya Moldvai; Regina Raffay; Catherine Cervi; Ildikó Krencz; Viktória Zsiros; András Jeney; Gábor Petővári
Journal:  Cancer Metastasis Rev       Date:  2022-01-14       Impact factor: 9.264

5.  MiR-21 Suppresses Anoikis through Targeting PDCD4 and PTEN in Human Esophageal Adenocarcinoma.

Authors:  Meng-Ya Zhao; La-Mei Wang; Jing Liu; Xing Huang; Jing Liu; Ya-Fei Zhang
Journal:  Curr Med Sci       Date:  2018-04-30

6.  Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread.

Authors:  Lydia Lartigue; Candice Merle; Pauline Lagarde; Lucile Delespaul; Tom Lesluyes; Sophie Le Guellec; Gaelle Pérot; Laura Leroy; Jean-Michel Coindre; Frédéric Chibon
Journal:  Oncogene       Date:  2020-04-02       Impact factor: 9.867

Review 7.  microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models.

Authors:  Ulrich H Weidle; Ulrich Brinkmann; Simon Auslaender
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

Review 8.  The potential role of leptin in tumor invasion and metastasis.

Authors:  Amitabha Ray; Margot P Cleary
Journal:  Cytokine Growth Factor Rev       Date:  2017-11-11       Impact factor: 7.638

Review 9.  Long non-coding RNAs involved in different steps of cancer metastasis.

Authors:  P Suman; Y Chhichholiya; P Kaur; S Ghosh; A Munshi
Journal:  Clin Transl Oncol       Date:  2022-02-04       Impact factor: 3.405

Review 10.  The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies.

Authors:  Yogita Chhichholiya; Prabhat Suman; Sandeep Singh; Anjana Munshi
Journal:  Med Oncol       Date:  2021-07-16       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.